Paris, January 18th . 2018. Inotrem S.A., a biotechnology company specialized in the control of acute inflammatory syndromes such as septic shock, has appointed Martin
vel, ut felis eget dapibus Lorem in Phasellus dictum
We use cookies on this site to enhance your user experience.
By clicking any link on this page you are giving your consent for us to set cookies.
Ok, I agreePrivacy policy